Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.919
+0.023 (2.54%)
At close: Mar 9, 2026, 4:00 PM EDT
0.910
-0.009 (-0.99%)
After-hours: Mar 9, 2026, 4:09 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $6.57 million as of March 9, 2026. Its market cap has increased by 134.59% in one year.
Market Cap
6.57M
Enterprise Value
-12.67M
1-Year Change
134.59%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $6.57M, a decrease of -97.44%. That is a compound annual growth rate of -34.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.50M | -9.72% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 6.84M |
| Moolec Science | 6.79M |
| XTL Biopharmaceuticals | 6.73M |
| Creative Medical Technology Holdings | 6.57M |
| Aptorum Group | 6.56M |
| Theriva Biologics | 6.45M |
| Processa Pharmaceuticals | 6.41M |
| Aptevo Therapeutics | 6.39M |